VIVID VISION, INC.

Medtech · Private

Home-based visual field testing software and hardware system for glaucoma monitoring

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$1.6M
Federal grants
$1.6M
2 awards · 2023–2024
Rank in peer group#403 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
12 pending · first 2017
Rank in peer group#125 of 538

Capital timeline

20232024FEDERAL ↑EQUITY ↓Cumulative $1.6M$839K$786K
20232024FEDERAL ↑EQUITY ↓Cumulative $1.6M$839K$786K

Latest events

  • Federal grantHealth and Human S · Phase II · Clustered home assessment of visual fields in patients with glaucoma$786K
  • Federal grantHealth and Human S · Phase II · Clustered home assessment of visual fields in patients with glaucoma$839K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#125 · top 23%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 4 granted of 16
Show all 16 patent records
  • Apparatus, Systems, And Methods For Vision Assessment And TreatmentSep 23, 2025 · US 12,419,513Granted
  • Systems And Methods For Vision AssessmentDec 10, 2024 · US 12,161,410Granted
  • Interactive System For Vision Assessment And CorrectionMay 9, 2024 · Application 18491002Pending
  • Systems, Methods, And Devices For Vision Assessment And TherapyNov 30, 2023 · Application 18450227Pending
  • Apparatus, Systems, And Methods For Vision Assessment And TreatmentOct 24, 2023 · US 11,793,403Granted
  • Interactive System For Vision Assessment And CorrectionMar 18, 2021 · Application 16880645Pending
  • Systems And Methods For Vision AssessmentMay 23, 2019 · Application 16191324Pending
  • Interactive System for Vision Assessment and CorrectionNov 30, 2017 · Application 15617885Pending
  • Interactive System for Vision Assessment and CorrectionJul 18, 2017 · US 9,706,910Granted
  • Systems, Methods, And Devices For Vision Assessment And TherapyApplication 63155141Pending
  • Systems, Methods, And Devices For Vision Assessment And TherapyApplication 63155720Pending
  • Systems And Methods For Visual Field AnalysisApplication PCTUS2018061128Pending
  • Apparatus, Systems, And Methods For Vision Assessment And TreatmentApplication PCTUS2021022619Pending
  • Systems And Methods For Vision AssessmentApplication 62586151Pending
  • Systems, Methods, And Devices For Vision Assessment And TherapyApplication 63215182Pending
  • Systems, Methods, And Devices For Vision Assessment And TherapyApplication PCTUS2022018388Pending
  • GrailSimilar federal contract value in Medtech · null in contracts
  • PARATECHS CORPSimilar federal contract value in Medtech · null in contracts
  • Vital Connect, Inc.Similar federal contract value in Medtech · null in contracts
  • CIRCULATECH LLCSimilar federal contract value in Medtech · null in contracts
  • Nomo Diagnostics, Inc.Similar federal contract value in Medtech · null in contracts
  • QAS.AI INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .